Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SH2B adapter protein 2 (Human) | BDBM484752 (1-(4-{6-[(3R)-3-amino-1,3-dihydrospiro[indene-2,4&...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484753 (US10934302, Example 2) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484754 (US10934302, Example 3) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484755 (US10934302, Example 4) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484756 (US10934302, Example 5) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484757 (US10934302, Example 6) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484758 (US10934302, Example 7) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484759 (US10934302, Example 8) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484760 (US10934302, Example 9) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484761 (US10934302, Example 10) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484762 (US10934302, Example 11) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484763 (US10934302, Example 12) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484764 (US10934302, Example 13 | US10934302, Example 15) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484765 (US10934302, Example 14) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484768 (US10934302, Example 17) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484769 (US10934302, Example 18) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484771 (US10934302, Example 20) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484772 ((3R)-1′-[6-amino-5-(2,3-dichlorophenyl)pyraz...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484773 (US10934302, Example 22) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484775 (US10934302, Example 24) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484776 (US10934302, Example 25) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484777 (US10934302, Example 26) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484778 (US10934302, Example 27) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484779 (US10934302, Example 28) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484780 (US10934302, Example 29) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484781 (US10934302, Example 30) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484782 (US10934302, Example 31) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484783 (US10934302, Example 32) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484784 (US10934302, Example 33) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484785 (US10934302, Example 34) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484786 (US10934302, Example 35) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484787 (US10934302, Example 36) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484788 (US10934302, Example 37) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484789 (US10934302, Example 38) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484790 (US10934302, Example 39) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484792 (US10934302, Example 41) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484793 (US10934302, Example 42) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484794 (US10934302, Example 43) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484795 (US10934302, Example 44) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484796 (US10934302, Example 45) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484797 (US10934302, Example 46) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484798 (US10934302, Example 47) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484799 (US10934302, Example 48) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484800 (US10934302, Example 49) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484801 (US10934302, Example 50) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484802 (US10934302, Example 51) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484803 (US10934302, Example 52) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484804 (US10934302, Example 53) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484805 (US10934302, Example 54) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SH2B adapter protein 2 (Human) | BDBM484806 (US10934302, Example 55) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Relay Therapeutics, Inc. US Patent | Assay Description SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st... | US Patent US10934302 (2021) BindingDB Entry DOI: 10.7270/Q2ZW1Q1S | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 294 total ) | Next | Last >> |